ArticleClinical pharmacology and therapeutics2026
Is a Clinical Trial With a Non-Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK.
Jin Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.